Recent Progress in Mitochondria-Targeting-Based Nanotechnology for Cancer Treatment

Nanoscale ◽  
2021 ◽  
Author(s):  
Jingbo Qin ◽  
Ningqiang Gong ◽  
Zhihuan Liao ◽  
Shouwen Zhang ◽  
Peter S. Timashev ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Targeted Delivery ◽  
Recent Progress ◽  
Proliferation And Apoptosis ◽  
Cancerous Cells ◽  
Mitochondria Targeting

Mitochondria play critical roles in the regulation of the proliferation and apoptosis of cancerous cells. Nanosystems for targeted delivery of cargos to mitochondria for cancer treatment have attracted increasing attention...

Targeted Delivery of siRNA Therapeutics using Ligand Mediated Biodegradable Polymeric Nanocarriers

2018 ◽  
Vol 24 (16) ◽  
pp. 1788-1800 ◽  
Author(s):  
Kye-Soo Cho ◽  
Seo-Jin Hong ◽  
Min-Hye Ahn ◽  
Sukdeb Pal ◽  
Pill-Hoon Choung ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Delivery System ◽  
Targeted Delivery ◽  
Sirna Delivery ◽  
Public Health Issue ◽  
Magic Bullet ◽  
Bodily Fluids ◽  
Low Cytotoxicity ◽  
Genetic And Environmental Factors ◽  
Sirna Delivery System

Background: Cancer poses a major public health issue, is linked with high mortality rates across the world, and shows a strong interplay between genetic and environmental factors. To date, common therapeutics, including chemotherapy, immunotherapy, and radiotherapy, have made significant contributions to cancer treatment, although diverse obstacles for achieving the permanent “magic bullet” cure have remained. Recently, various anticancer therapeutic agents designed to overcome the limitations of these conventional cancer treatments have received considerable attention. One of these promising and novel agents is the siRNA delivery system; however, poor cellular uptake and altered siRNA stability in physiological environments have limited its use in clinical trials. Therefore, developing the ideal siRNA delivery system with low cytotoxicity, improved siRNA stability in the body’s circulation, and prevention of its rapid clearance from bodily fluids, is rapidly emerging as an innovative therapeutic strategy to combat cancer. Moreover, active targeting using ligand moieties which bind to over-expressed receptors on the surface of cancer cells would enhance the therapeutic efficiency of siRNA. Conclusion: In this review, we provide 1) an overview of the non-viral carrier associated with siRNA delivery for cancer treatment, and 2) a description of the five major cancer-targeting ligands.

Potential of Nanoparticles in Combating Candida Infections

2019 ◽  
Vol 16 (5) ◽  
pp. 478-491 ◽  
Author(s):  
Faizan Abul Qais ◽  
Mohd Sajjad Ahmad Khan ◽  
Iqbal Ahmad ◽  
Abdullah Safar Althubiani
Keyword(s):  
Targeted Delivery ◽  
Recent Progress ◽  
Antifungal Agents ◽  
Fungal Infections ◽  
Fold Increase ◽  
Antifungal Drugs ◽  
Low Toxicity ◽  
Candida Infections ◽  
Made In

Aims: The aim of this review is to survey the recent progress made in developing the nanoparticles as antifungal agents especially the nano-based formulations being exploited for the management of Candida infections. Discussion: In the last few decades, there has been many-fold increase in fungal infections including candidiasis due to the increased number of immunocompromised patients worldwide. The efficacy of available antifungal drugs is limited due to its associated toxicity and drug resistance in clinical strains. The recent advancements in nanobiotechnology have opened a new hope for the development of novel formulations with enhanced therapeutic efficacy, improved drug delivery and low toxicity. Conclusion: Metal nanoparticles have shown to possess promising in vitro antifungal activities and could be effectively used for enhanced and targeted delivery of conventionally used drugs. The synergistic interaction between nanoparticles and various antifungal agents have also been reported with enhanced antifungal activity.

Innovatory role of nanomaterials as bio-tools for treatment of cancer

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Khuram Shahzad Ahmad ◽  
Muntaha Talat ◽  
Shaan Bibi Jaffri ◽  
Neelofer Shaheen
Keyword(s):  
Cancer Treatment ◽  
Cancer Therapeutics ◽  
Physicochemical Characteristics ◽  
Global Scale ◽  
Current Review ◽  
Anti Cancer ◽  
Different Types ◽  
Cancerous Cells

AbstractConventional treatment modes like chemotherapy, thermal and radiations aimed at cancerous cells eradication are marked by destruction pointing the employment of nanomaterials as sustainable and auspicious materials for saving human lives. Cancer has been deemed as the second leading cause of death on a global scale. Nanomaterials employment in cancer treatment is based on the utilization of their inherent physicochemical characteristics in addition to their modification for using as nano-carriers and nano-vehicles eluted with anti-cancer drugs. Current work has reviewed the significant role of different types of nanomaterials in cancer therapeutics and diagnostics in a systematic way. Compilation of review has been done by analyzing voluminous investigations employing ERIC, MEDLINE, NHS Evidence and Web of Science databases. Search engines used were Google scholar, Jstore and PubMed. Current review is suggestive of the remarkable performance of nanomaterials making them candidates for cancer treatment for substitution of destructive treatment modes through investigation of their physicochemical characteristics, utilization outputs and long term impacts in patients.

Biomedical applications of methionine-based systems

2021 ◽  
Author(s):  
Jie Liu ◽  
Jun Huang ◽  
Peikun Xin ◽  
Guiting Liu ◽  
Jun Wu
Keyword(s):  
Liver Disease ◽  
Cancer Treatment ◽  
Biomedical Applications ◽  
Recent Progress ◽  
Functional Modification ◽  
Disease Therapy ◽  
Derivatives Of

Spurred by the structure, metabolism, and derivatives of methionine, this review systematically summarizes its recent progress in functional modification, cancer treatment, liver disease therapy.

scholarly journals AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment

2017 ◽  
Vol 5 (1) ◽  
pp. 151-159 ◽  
Author(s):  
Renata Jaskula-Sztul ◽  
Guojun Chen ◽  
Ajitha Dammalapati ◽  
April Harrison ◽  
Weiping Tang ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Cancer Treatment ◽  
Targeted Delivery ◽  
Medullary Thyroid Cancer ◽  
Medullary Thyroid

Multifunctional unimolecular micelles conjugated with KE108, a superior MTC-targeting ligand, were developed for targeted delivery of AB3 to treat MTC.

Simulation of cancer treatment using the MATLAB SimBiology application

2021 ◽  
Vol 14 (3) ◽  
pp. 90-96
Author(s):  
Anastasia Goncharova ◽  
Maria Vil'
Keyword(s):  
Mathematical Model ◽  
Cancer Treatment ◽  
Interference Competition ◽  
The Body ◽  
Continuous Treatment ◽  
Constant Concentration ◽  
Application Package ◽  
The Mathematical Model ◽  
Cancerous Cells

The paper presents the implementation of the mathematical model of cancer taking into account interference competition and the model of continuous treatment with a constant concentration of the drug in the patient's blood. The implementation was carried out using the MATLAB SimBiology application package. The principle of implementation of different stages of the course of the disease within the framework of one model is described. On the basis of the constructed models and SimBiology tools, a modification was carried out that implements the discrete administration of doses of the drug in courses and takes into account its dynamics in the body, taking into account the assumption that the drug is consumed only to suppress cancerous cells.

Novel Mitochondrial Targeting Multifunctional Surface Charge-Reversal Polymeric Nanoparticles for Cancer Treatment

2019 ◽  
Vol 15 (11) ◽  
pp. 2151-2163 ◽  
Author(s):  
Lei Fang ◽  
Huaying Fan ◽  
Chunjing Guo ◽  
Linhan Cui ◽  
Peng Zhang ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Targeted Delivery ◽  
Polymeric Nanoparticles ◽  
In Vitro Cytotoxicity ◽  
Hydrodynamic Diameter ◽  
Mitochondrial Targeting ◽  
Anticancer Activities ◽  
Charge Reversal

Polymeric nanoparticles were widely used as delivery vehicles for targeted delivery of anticancer drugs, because of their targeting property and versatility. Mitochondria are one of the important organelles that regulate the apoptosis of cancer cells and can be considered as a pivotal target for cancer treatment. A pH-responsive charge-reversal and mitochondrial targeting nanoparticles, Vitamin B6-oligomeric hyaluronic acid-dithiodipropionic acid-berberine (B6-oHA-SS-Ber), were prepared in this study. Ber is a lipophilic cation that was conjugated with oHA through disulfide bonds to produce mitochondria-targeted conjugates (oHA-SS-Ber). B6 was conjugated to oHA to obtain B6-oHA-SS-Ber and the two types of Cur-loaded nanoparticles (Cur-NPs) were formulated by the dialysis method. Due to pKa of B6, the charge they carried in the tumor tissue acidic microenvironment can be transferred from negative charge to positive charge, further targeting mitochondria. In our study, we successfully synthesized B6-HA-SS-Ber and characterized the structure by 1H-NMR. According to the results of transmission electron microscopy (TEM), we found that the B6-oHA-SS-Ber/Cur micelles could self-assembled in water to form spherical nanoparticles, with a hydrodynamic diameter of 172.9±13 nm. Moreover, in vitro cytotoxicity, cellular uptake, lysosome escape and mitochondrial distribution researches revealed the better effect of B6-oHA-SS-Ber/Cur micelles in comparison to oHA-SS-Ber/Cur. In vivo anticancer activities indicated that the B6-oHA-SS-Ber/Cur micelles exhibited effective inhibition of tumor growth.

Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment

2020 ◽  
Vol 208 ◽  
pp. 112831 ◽  
Author(s):  
Xiaopeng Peng ◽  
Zhiqiang Sun ◽  
Peihua Kuang ◽  
Jianjun Chen
Keyword(s):  
Cancer Treatment ◽  
Recent Progress ◽  
Hdac Inhibitors ◽  
Dual Targeting

scholarly journals Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies

Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 2783
Author(s):  
Qi-Yao Wei ◽  
Yan-Ming Xu ◽  
Andy T. Y. Lau
Keyword(s):  
Solid Tumors ◽  
Targeted Delivery ◽  
Recent Progress ◽  
Loading Capacity ◽  
Chemotherapeutic Drugs ◽  
Conventional Chemotherapy ◽  
Solid Malignancies ◽  
Wide Range ◽  
Target Sites ◽  
The Face

Conventional chemotherapy is still an important option of cancer treatment, but it has poor cell selectivity, severe side effects, and drug resistance. Utilizing nanoparticles (NPs) to improve the therapeutic effect of chemotherapeutic drugs has been highlighted in recent years. Nanotechnology dramatically changed the face of oncology by high loading capacity, less toxicity, targeted delivery of drugs, increased uptake to target sites, and optimized pharmacokinetic patterns of traditional drugs. At present, research is being envisaged in the field of novel nano-pharmaceutical design, such as liposome, polymer NPs, bio-NPs, and inorganic NPs, so as to make chemotherapy effective and long-lasting. Till now, a number of studies have been conducted using a wide range of nanocarriers for the treatment of solid tumors including lung, breast, pancreas, brain, and liver. To provide a reference for the further application of chemodrug-loaded nanoformulations, this review gives an overview of the recent development of nanocarriers, and the updated status of their use in the treatment of several solid tumors.

scholarly journals Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: a study using zebrafish as a cancer model

RSC Advances ◽  
2020 ◽  
Vol 10 (35) ◽  
pp. 20682-20690 ◽  
Author(s):  
Szu-Yuan Wu ◽  
Hsiao-Ying Chou ◽  
Hsieh-Chih Tsai ◽  
Rajeshkumar Anbazhagan ◽  
Chiou-Hwa Yuh ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Amino Acid ◽  
Controlled Release ◽  
Cancer Treatment ◽  
Targeted Delivery ◽  
Chemotherapeutic Drug ◽  
Cancer Model

The use of nanomaterials for drug delivery offers many advantages including the controlled release and their targeted delivery.

Sign in / Sign up

Export Citation Format

Share Document